Dermatol. praxi. 2024;18(2):74-77 | DOI: 10.36290/der.2024.015
Local hyperhidrosis - an underdiagnosed problem burdening the patient
- Lékařské centrum zdraví a estetické péče, s. r. o., Brno
Primary hyperhidrosis is a condition of excessive local production of sweat that does not ensure thermoregulation of the given person. This disease puts the patient in unpleasant situations both in his working life and in his free time, and burdens his psyche. However, several treatment options can improve the daily life of such affected people. The first topical anticholinergic with the active ingredient glycopyrronium in the form of a cream brings a new treatment option.
Keywords: hyperhidrosis, quality of life, glycopyrronium.
Accepted: May 29, 2024; Published: June 3, 2024 Show citation
References
- Doolittle J, Walker P, Mills T, et al. Hyperhidrosis: an update on prevalence and severity in the United States. Archives of dermatological research. 2016;308(10):743-749. doi: 10.1007/s00403-016-1697-9.
Go to original source... 
Go to PubMed... - Kamudoni P, Mueller B, Halford J, et al. The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation. Health and quality of life outcomes. 2017;15 (1):121. doi: 10.1186/s12955-017-0693-x. Go to original source... Go to PubMed...
- Bahar R, Zhou P, Liu Y, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol. 2016;75(6):1126-1133. doi: 10.1016/j.jaad.2016. 07. 001. Go to original source...
- Walling HW. Clinical differentiation of primary from secondary hyperhidrosis. J Am Acad Dermatol. 2011;64(4):690-695. doi: 10.1016/j.jaad.2010. 03. 013. Go to original source...
- AbelsC, Soeberdt M, Kilic A, et al. A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. Br J Dermatol.2021;185(2):315-322. doi: 10.1111/bjd.19810. Go to original source... Go to PubMed...
- Szeimies RM, Abels Ch, Kilic A, et al. Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3 b trial. Journal of the European Academy of Dermatology and Venereology: JEADV. 2023;37(4):823-830. doi: 10.1111/jdv.18843. Go to original source... Go to PubMed...